AA
Akhlas Ahmed
About Akhlas Ahmed
Data last updated:
Akhlas Ahmed is a Director at Copmed Pharmaceuticals Private Limited (since 2021), Director at Mankind Prime Labs Private Limited (since 2020) and Director at Mankind Agritech Private Limited (since 2022), and holds 8 more current directorships. The companies operate in Pharma, Agriculture and Packaging. The 9 current companies with reported revenue have a combined latest revenue of ₹1,834 Cr; the largest is Copmed Pharmaceuticals Private Limited at ₹438 Cr (FY 2025). Earlier, Akhlas Ahmed was a Ceo at Jaspack Industries Private Limited (2018–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Copmed Pharmaceuticals Private Limited U74899DL1988PTC033151 | Director | 01 Mar 2021 | 1988 | ₹438 Cr (FY 2025) | Active |
 Mankind Prime Labs Private Limited U51909DL2020PTC370864 | Director | 26 Nov 2020 | 2020 | ₹332 Cr (FY 2025) | Active |
| Mankind Agritech Private Limited U24299DL2022PTC396241 | Director | 06 Apr 2022 | 2022 | ₹277 Cr (FY 2025) | Active |
 Packtime Innovations Private Limited U36912DL2015PTC281265 | Director | 17 May 2024 | 2015 | ₹263 Cr (FY 2025) | Active |
 Relax Pharmaceuticals Private Limited U24231DL1997PTC461314 | Director | 01 Mar 2021 | 1997 | ₹216 Cr (FY 2024) | Active |
 Mediforce Healthcare Private Limited U51397DL2001PTC461317 | Director | 01 Mar 2021 | 2001 | ₹105 Cr (FY 2024) | Active |
 Sirmour Remedies Private Limited U15311HP1989PTC009770 | Director | 01 Mar 2021 | 1989 | ₹98.10 Cr (FY 2025) | Active |
| Mankind Life Sciences Private Limited U24100DL2020PTC369904 | Director | 17 Sep 2021 | 2020 | ₹90.12 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Jaspack Industries Private Limited U36912DL2015PTC277915 | Ceo | 06 Sep 2018 | 2015 | ₹3.65 Cr (FY 2024) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Akhlas Ahmed
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Akhlas Ahmed
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Akhlas Ahmed
Akhlas Ahmed currently holds 11 directorships: Copmed Pharmaceuticals Private Limited (Director, since 01 Mar 2021, revenue ₹438 Cr (FY 2025)); Mankind Prime Labs Private Limited (Director, since 26 Nov 2020, revenue ₹332 Cr (FY 2025)); Mankind Agritech Private Limited (Director, since 06 Apr 2022, revenue ₹277 Cr (FY 2025)); Packtime Innovations Private Limited (Director, since 17 May 2024, revenue ₹263 Cr (FY 2025)); Relax Pharmaceuticals Private Limited (Director, since 01 Mar 2021, revenue ₹216 Cr (FY 2024)); and 6 more.
Akhlas Ahmed was first appointed on 06 Sep 2018 as Ceo at Jaspack Industries Private Limited. The most recent appointment on record is 08 Aug 2024 at Mankind Consumer Products Private Limited.
The 9 current companies of Akhlas Ahmed that report revenue have a combined latest revenue of ₹1,834 Cr: Copmed Pharmaceuticals Private Limited ₹438 Cr (FY 2025); Mankind Prime Labs Private Limited ₹332 Cr (FY 2025); Mankind Agritech Private Limited ₹277 Cr (FY 2025); Packtime Innovations Private Limited ₹263 Cr (FY 2025); Relax Pharmaceuticals Private Limited ₹216 Cr (FY 2024); and 4 more.
Akhlas Ahmed held 1 earlier board appointment: Jaspack Industries Private Limited (Ceo, 06 Sep 2018 to 07 Aug 2024).
The current boards of Akhlas Ahmed's companies include Abhay Kumar Srivastava (Copmed Pharmaceuticals Private Limited), Anju Kumari Jha (Copmed Pharmaceuticals Private Limited), Bhupendra Kaushik (Copmed Pharmaceuticals Private Limited), Jagmohan Sharma (Copmed Pharmaceuticals Private Limited), Veer Singh Pal (Copmed Pharmaceuticals Private Limited), Deepak Gupta (Mankind Prime Labs Private Limited), among others.